Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Pelizaeus-Merzbacher disease (PMD) is a rare, X-linked neurodegenerative disorder.
• It primarily affects the central nervous system's white matter.
• PMD is caused by mutations in the proteolipid protein 1 (PLP1) gene.

Purpose of the Study:

• To investigate the genetic basis of PMD in a cohort of male patients.
• To identify mutations in the PLP1 gene associated with PMD.
• To correlate genotype with phenotype in patients with PMD.

Main Methods:

• Mutation analysis was performed on 133 male patients with suspected PMD.
• Single-strand conformation polymorphism (SSCP) analysis was used for coding exons of PLP1.
• Quantitative real-time PCR (qPCR) was employed to detect gene duplications.
• Large deletions were also investigated.

Main Results:

• Pathogenic mutations in the PLP1 gene were identified in 35 out of 133 patients (26.3%).
• Seventeen novel sequence variants, including single base substitutions and small rearrangements, were found in 21 patients (15.8%).
• Twelve patients (9.0%) had duplications of the entire PLP1 gene, presenting with variable phenotypes.
• Two patients had large deletions encompassing the PLP1 gene.

Conclusions:

• Mutations in the PLP1 gene are a significant cause of PMD in male patients.
• A variety of PLP1 mutations, including missense mutations, duplications, and deletions, underlie PMD.
• Genetic analysis of PLP1 is crucial for diagnosing PMD and understanding its variable clinical manifestations.